XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,815,672 | -9.7% | 111,700 | +1.7% | 0.00% | 0.0% |
| Q2 2023 | $4,227,300 | +16.6% | 109,800 | +8.4% | 0.00% | +50.0% |
| Q1 2023 | $3,625,527 | -18.4% | 101,300 | -10.1% | 0.00% | -33.3% |
| Q4 2022 | $4,443,761 | +13.6% | 112,700 | +4.0% | 0.00% | 0.0% |
| Q3 2022 | $3,913,000 | +19.3% | 108,400 | +0.6% | 0.00% | +50.0% |
| Q2 2022 | $3,279,000 | +10.0% | 107,800 | +10.6% | 0.00% | 0.0% |
| Q1 2022 | $2,981,000 | +9.2% | 97,500 | +11.6% | 0.00% | 0.0% |
| Q4 2021 | $2,730,000 | +181.7% | 87,400 | +37.9% | 0.00% | +100.0% |
| Q3 2021 | $969,000 | -16.0% | 63,400 | +2.4% | 0.00% | 0.0% |
| Q2 2021 | $1,153,000 | +0.6% | 61,900 | -3.3% | 0.00% | 0.0% |
| Q1 2021 | $1,146,000 | +19.3% | 64,000 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $961,000 | +38.9% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $692,000 | -11.7% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $784,000 | – | 62,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |